Atlantic American: Q4 Earnings Snapshot

Atlantic American Corp. (AAME) reported Q4 net income of $1.3M, or 6 cents per share. Adjusted earnings were 1 cent per share. Revenue was $51.3M. For the year, net income was $6M, or 28 cents per share, with revenue of $210.4M. Shares closed at $1.04, down from $3.08 a year ago.

Original reporting
Published Oct 16, 2026, 9:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 16, 2026, 9:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Atlantic American: Q4 Earnings Snapshot — source image
Decision brief

The 30-second read

$AAMEBearishLow
01

Why it matters

The earnings release shows modest profitability but a significant share price decline, indicating negative market reaction.

02

Market read

The report is primarily relevant to traders holding or considering AAME; broader market impact is negligible.

03

What to watch

Potential hidden cost pressures or upcoming regulatory changes affecting the insurance niche are not discussed.

Relevance 5/10Novelty 5/10Timing: after-hours Friday

Background

Atlantic American Corp. (AAME) is a small‑cap insurance company that disclosed its Q4 and full‑year results via an automated Zacks feed.

Company-level read

Ticker impact

$AAMEBearishMedium confidence
Context

Atlantic American Corp. reported Q4 net income of $1.3M, EPS of $0.06 and annual net income of $6M, with shares closing at $1.04 after a sharp decline from $3.08 a year ago.

Expected impact

likely continued pressure as the market prices in the earnings disappointment and low revenue.

Evidence & confidence

The company posted modest earnings and a sharp share price decline, indicating downside risk for the near term.

Market effects

Minimal impact on the broader insurance sector due to the company's small size.

Limited to investors tracking micro‑cap insurance stocks.

None

Counterpoint

The steep price drop may present a short‑term buying opportunity if the market overreacts to a small‑cap earnings miss.

Key entities

  • Atlantic American Corp.

    US‑listed insurance firm (ticker AAME) reporting Q4 earnings.

Related articles

$PTHSMed

Pelthos (PTHS) Q3 2026 Earnings Call Transcript

Pelthos (PTHS) reported Q3 2026 net revenue of $15.2M, up 114% YoY, with Zelsuvmi treating 31,000 patients. Formulary coverage expanded to 70% of commercial lives. The company announced a deal with Castle Creek Biosciences, aiming to leverage synergies in dermatology and cell/gene therapy markets. Xepi and Xeglyze launches are planned for 2027.

$BMNRMedAI 8/10

Bitmine’s ($BMNR) $6.3 Billion Loss Highlights Overall Risks for Strategy ($MSTR) and Other Treasury Firms as MSCI Tightens Rules

Bitmine Immersion Technologies (BMNR) reported a $6.3B net loss for fiscal 2026, driven by $6.23B in unrealized losses on digital-asset holdings, primarily ether. The company held 5.9M ether tokens and 211 bitcoin at year-end. Operating revenue was $125M, with staking contributing 97%. MSCI's updated index rules may impact BMNR and other crypto-focused treasury firms, including Strategy (MSTR).

HighAI 8/10

Merck KGaA Earnings Call Signals Stronger Growth Ahead

Merck KGaA (MKKGY) reported Q3 earnings with accelerated growth, raised full-year guidance, and announced strategic investments. Key highlights include 5.1% organic sales growth, EUR 1.66B operating cash flow, and plans to acquire Silence Therapeutics. Management emphasized growth in biomanufacturing, semiconductors, and rare diseases, while noting Mavenclad's declining sales and softer demand in consumer electronics.

$EZPWMed

EZCORP shares fall despite record Q4 as costs overshadow beat

EZCORP (EZPW) reported Q4 revenue of $447M, beating estimates, with full-year revenue up 30% to $1.7B and adjusted EBITDA up 47% to $277M. Despite strong results, shares fell 4.13% due to concerns about labor costs and integration timing in Latin America. Insiders filed SEC disclosures, and short-sale activity increased ahead of the earnings release.

$FLNTMed

What Fluent (FLNT) Said on Its Q3 Earnings Call

Fluent (FLNT) reported a Q3 net loss of $3.1M, improved from last year. Adjusted EBITDA loss narrowed to $43K, with positive EBITDA expected in Q4. Cash decreased to $11.4M, with $31.5M in short-term debt. The company guided toward high 20% gross margins and potential double-digit revenue growth in 2027, while testing in-store and loyalty offerings.